Edition:
United States

Medicines Co (MDCO.OQ)

MDCO.OQ on NASDAQ Stock Exchange Global Select Market

39.85USD
17 Aug 2018
Change (% chg)

$0.32 (+0.81%)
Prev Close
$39.53
Open
$39.37
Day's High
$39.89
Day's Low
$39.37
Volume
110,674
Avg. Vol
261,469
52-wk High
$41.57
52-wk Low
$24.45

Chart for

About

The Medicines Company is a global biopharmaceutical company. The Company is focused on advancing the treatment of acute and intensive care patients through the delivery of medicines to the hospital marketplace around the world. It markets Angiomax (bivalirudin), Ionsys (fentanyl iontophoretic transdermal system), Minocin... (more)

Overall

Beta: 0.77
Market Cap(Mil.): $2,940.59
Shares Outstanding(Mil.): 73.79
Dividend: --
Yield (%): --

Financials

  MDCO.OQ Industry Sector
P/E (TTM): -- 28.29 30.45
EPS (TTM): -2.40 -- --
ROI: -26.64 12.92 12.63
ROE: -158.61 14.94 14.82

BRIEF-Medicines Co Says CEO Clive A. Meanwell's 2017 Total Compensation Was $7.6 Million

* MEDICINES CO SAYS CEO CLIVE A. MEANWELL'S 2017 TOTAL COMPENSATION WAS $7.6 MILLION VERSUS $6.7 MILLION IN 2016 – SEC FILING Source : https://bit.ly/2KsU3bs Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Apr 30 2018

BRIEF-The Medicines Co Reports Q1 GAAP Loss Per Share $1.14 From Continuing Operations

* Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.76 FROM CONTINUING OPERATIONS

Apr 25 2018

BRIEF-The Medicines Company Announces Chief Financial Officer Transition

* THE MEDICINES COMPANY ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITION

Mar 28 2018

BRIEF-Medicines Co Says Board Appointed Christopher Visioli As CFO

* MEDICINES - ON MARCH 21, BOARD APPOINTED CHRISTOPHER VISIOLI CFO AND TREASURER OF COMPANY, EFFECTIVE IMMEDIATELY

Mar 27 2018

Medicines Company cuts board size, activist Denner to get more control

Medicines Company on Thursday said it was cutting the number of directors on its board, a move that could give billionaire investor Alex Denner greater control.

Mar 01 2018

Medicines Company cuts board size, activist Denner to get more control

March 1 Medicines Company on Thursday said it was cutting the number of directors on its board, a move that could give billionaire investor Alex Denner greater control.

Mar 01 2018

BRIEF-The Medicines Company Appoints Sarah Schlesinger To Its Board Of Directors

* THE MEDICINES COMPANY APPOINTS SARAH SCHLESINGER TO ITS BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

Feb 27 2018

BRIEF-The Medicines Q4 GAAP Loss Per Share $2.19 From Continuing Operations

* THE MEDICINES COMPANY REPORTS FOURTH-QUARTER AND FULL-YEAR 2017 BUSINESS AND FINANCIAL RESULTS

Feb 21 2018

BRIEF-The Medicines Company Reaches Enrollment Target For Orion-9 Ahead Of Schedule

* THE MEDICINES COMPANY REACHES ENROLLMENT TARGET FOR ORION-9 AHEAD OF SCHEDULE Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Feb 20 2018

Earnings vs. Estimates